Thromboelastography (ADP Activation) Detection Test Kit

A specialized reagent kit for assessing platelet aggregation function through arachidonic acid and adenosine diphosphate activation pathways. Provides evaluation of platelet-dependent hemostatic mechanisms using thromboelastographic analysis.

Test kit for assessment of blood coagulation factors and platelet function. Evaluates hemostatic disorders and monitors anticoagulation therapy.

Multi-parameter reagent kit for automated platelet aggregation testing using optical and magnetic methodologies. Includes standardized reagents for AA, ADP, collagen, and ristocetin pathways.

A diagnostic test kit for D-dimer detection. Used for thromboembolism assessment and coagulation disorder evaluation.

Complete diagnostic testing kit for thrombosis assessment and risk stratification. This product enables rapid identification of thrombotic conditions in clinical settings.

Rapid assay for fibrin degradation product measurement. Aids in excluding thromboembolism and disseminated intravascular coagulation.

A test kit that uses sodium citrate anticoagulated whole blood, where sodium citrate complexes calcium ions in blood. Upon supplementation of appropriate calcium ions and addition of accelerants, the anticoagulated blood is induced to coagulate.

Quantitative test kit for D-dimer measurement in blood plasma. Used for diagnosis of thrombotic and fibrinolytic disorders.

A ready-to-use liquid reagent for activated partial thromboplastin time testing, included in standard coagulation panels for comprehensive hemostasis assessment and disease state management.

In vitro diagnostic reagent for blood coagulation assessment. Supports rapid evaluation of clotting factors and function.

A homogeneous chemiluminescence immunoassay for measuring percentage of platelets expressing CD62p marker. Used to assess platelet activation status in hematological research and diagnostics.

Rapid diagnostic test for quantitative measurement of D-dimer in plasma for thromboembolism assessment. Supports clinical evaluation of venous thromboembolism risk.